Lancet Oncology
Cancer researchers discover new type of retinoblastoma in babies
A team of Canadian and international cancer researchers led by Dr. Brenda Gallie at the Princess Margaret Cancer Centre, University Health Network (UHN), has discovered a new type of retinoblastoma, a rapidly developing eye ...
Cancer
Mar 12, 2013 |
5 / 5 (2) |
0
|
Breast cancer and periods: Link more important in specific cancers
(Medical Xpress)—The younger a woman starts her periods, and the later she finishes, the more at risk she is from developing breast cancer. Now a new study led by Oxford researchers shows that these factors ...
Cancer
Oct 18, 2012 |
3 / 5 (1) |
0
|
Latin America risks being 'overwhelmed' by burgeoning cancer epidemic
Latin America is facing an alarming increase in cancer rates, and unless urgent action is taken to prevent cancers, improve health-care systems and facilities, access to vital medical care, and treatment of poor people, the ...
Cancer
Apr 25, 2013 |
not rated yet |
0
3-D breast screens improve detection and reduce false positives
Three-dimensional breast screens (mammograms) could offer substantial improvements in cancer detection and reducing false positives when used in conjunction with traditional two-dimensional mammograms, according to the results ...
Cancer
Apr 24, 2013 |
5 / 5 (1) |
0
New drug shrinks brain tumours in melanoma patients
(Medical Xpress)—Australian researchers have given hope to patients with advanced melanoma by showing that a new drug targeting a common mutation in melanoma successfully shrank tumours that had spread to the brain.
Cancer
Oct 08, 2012 |
not rated yet |
0
|
Phase 3 trial confirms abiraterone acetate efficacy for patients with advanced prostate cancer
Results of a phase 3 trial published in The Lancet Oncology have confirmed that the drug abiraterone acetate (marketed as Zytiga) offers a significant survival benefit to patients with castration-resistant prostate cancer ...
Cancer
Sep 17, 2012 |
not rated yet |
0
Study drug is first to help patients with recurrent low-grade ovarian cancer
Low-grade serous ovarian cancer is less common and aggressive than the high-grade variety, yet exceptionally difficult to treat when frontline therapy fails.
Cancer
Feb 08, 2013 |
not rated yet |
0
|
Researchers discover breakthrough in ovarian cancer
Researchers at The University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center in Phoenix have discovered that many women with low-grade serous carcinoma of the ovary or peritoneum have seen their tumors ...
Cancer
Feb 14, 2013 |
5 / 5 (3) |
0
|
Study supports tobacco link to ovarian cancer
(Medical Xpress)—Researchers from Curtin University's School of Public Health have contributed to a comprehensive international study examining risk factors for ovarian cancer.
Cancer
Sep 12, 2012 |
not rated yet |
0
|
Oestrogen patches could offer a new treatment option for prostate cancer patients
Patches giving oestrogen through the skin could be an easy and safe alternative to the hormone therapies used to treat prostate cancer, according to new research published in the Lancet Oncology, today (Monday).
Cancer
Mar 04, 2013 |
not rated yet |
0
Childhood cancer in developing countries—a growing health threat that could be easily managed
Across the developing world, childhood cancer is on the rise, and mortality is high. Once thought of as a rich world disease, cancer is a growing health threat across low-income and middle-income countries (LMCs). A major ...
Cancer
Feb 19, 2013 |
not rated yet |
0
Drug trial offers hope to patients with advanced colorectal cancer
A new drug treatment could offer hope to patients with advanced colorectal cancer who were intolerant of or did not respond to standard treatments, according to an article published in the Lancet Oncology.
Cancer
Aug 27, 2012 |
not rated yet |
0
Study discovers gene signature that predicts prostate cancer survival
Researchers from Mount Sinai School of Medicine have identified a six-gene signature that can be used in a test to predict survival in men with aggressive prostate cancer, according to new research published in the October ...
Cancer
Oct 10, 2012 |
not rated yet |
0
Drug combination shrinks secondary brain tumours in breast cancer without substantial side effects of radiotherapy
The sizeable and increasing proportion of women with advanced breast cancer whose disease has spread to the brain could be effectively treated systemically with a combination of two drugs, sparing them the debilitating neurological ...
Cancer
Nov 01, 2012 |
5 / 5 (1) |
0
Painless skin rash predicts survival benefit from latest lung cancer drug, study finds
(Medical Xpress)—Elderly patients with advanced non small cell lung cancer (NSCLC) who developed a rash within 28 days of receiving the targeted drug erlotinib (Tarceva) survived on average 6.2 months, c ...
Cancer
Oct 17, 2012 |
not rated yet |
0
